• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Envista Holdings Corporation Announces Key Leadership Appointments

    7/15/24 4:10:00 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care
    Get the next $NVST alert in real time by email

    BREA, Calif., July 15, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced the following key leadership appointments:

    Envista Logo (PRNewsfoto/Envista Holdings Corporation)

    • Eric Hammes joins Envista as Chief Financial Officer
    • Stefan Nilsson joins Envista as President, Nobel Biocare
    • Veronica Acurio joins Envista as President, Ormco

    "It is a pleasure to welcome this trio of successful leaders to Envista," said Paul Keel, Chief Executive Officer. "Each brings experience in dental along with a proven track record of continuous improvement, leading with purpose, and creating value for all stakeholders. Today's announcement positions Envista even more strongly to advance our mission of partnering with dental professionals to improve patient lives."

    Eric Hammes – Chief Financial Officer

    Eric Hammes is appointed Chief Financial Officer effective August 8, 2024. He succeeds Stephen Keller who has served as Interim Principal Financial Officer since September 2023. Mr. Keller will return to his previous role leading investor relations.

    Mr. Hammes brings more than 25 years of operational and financial leadership to Envista. He joins the company from Rockwell Automation, where he served as Vice President, Corporate Financial Planning and Analysis. Prior to Rockwell, Eric had an extensive career at 3M where he held numerous financial and operational leadership positions including Senior Vice President Controller and Chief Accounting Officer, CFO of 3M Health Care Business Group, and Director Finance for the Orthodontic Products Division. 

    Mr. Keel said, "We are proud to have Eric join us as CFO. He is a transformational leader with a strong track record of delivering continuous improvement and increasing shareholder value. He has directly relevant experience in both dental and health care as well as multi-segment global businesses. Eric is well positioned to help our leadership team accelerate Envista's growth, expand our margins, and further advance our portfolio."

    Mr. Hammes said, "I am thrilled to join Envista at this exciting time in the company's history. Envista's leading brands in the most attractive dental segments, and its commitment to continuous improvement, positions Envista well for long-term value creation for all stakeholders."

    Stefan Nilsson – President, Nobel Biocare

    Stefan Nilsson is appointed President of Nobel Biocare, effective July 15, 2024.

    Most recently, Mr. Nilsson served as CEO of Colosseum Dental Group, which grew to be one of Europe's largest Dental Service Organizations under his leadership. Prior to Colosseum, Mr. Nilsson was CEO of GrandVision Brazil, a leading eyecare service provider. Further, he had a distinguished career at Nestle in a variety of operations, marketing, and general management roles around the world.

    Mr. Keel said, "It is my pleasure to welcome Stefan to Envista. As CEO of Colosseum Dental Group, Stefan led the company through a period of rapid growth and value creation. He has deep insights into the ever-evolving needs of our customers, and he is a passionate advocate for the digitization of dental workflows. I look forward to working with Stefan to accelerate growth at Nobel Biocare and further position us as a global leader in implant dentistry."

    Mr. Nilsson said, "It is an honor to join Envista as President of Nobel Biocare, the premier brand in implants. Nobel is the pioneer of implant innovation and well positioned to lead the future of this specialty. As a customer, I saw firsthand the strength of Nobel Biocare's innovation, their best-in-class clinical solutions, and the vibrant community of clinicians around the brand. I am delighted to be working with the Nobel team and our clinical partners to further advance our business and the future of implant dentistry."

    Veronica Acurio – President, Orthodontics

    Veronica Acurio is appointed President, Orthodontics effective August 2, 2024. 

    Ms. Acurio joins Envista from Solventum, a global medical device business recently spun off from 3M Company. Veronica has extensive experience in profitably growing global healthcare businesses. Most recently, she served as President of 3M's $5 billion Medical Solutions Division. Prior to that, she held various commercial, operational, and business leadership roles around the world including SVP of 3M Health Care in the Greater China region, Managing Director of 3M Taiwan, VP Business Development of 3M Health Care for Latin America, and Global Business Director of 3M Oral Care Division's Restorative business.

    Mr. Keel said, "We are delighted to welcome Veronica to Envista. She is an accomplished leader with a proven track record of leading dental and medical businesses all around the world. Her passionate focus on customers and innovation ideally positions Veronica to further advance Ormco as the partner of choice for orthodontic specialists."

    Ms. Acurio said, "I am humbled to join Envista as President of Orthodontics. Envista has long been a leader in orthodontics. The Ormco business has partnered with the orthodontic community for over 60 years bringing innovation in both bracket and wires and clear aligners. Spark™ aligners is one of the fastest growing brands in dental. It is a privilege to lead this business in helping orthodontists improve the smiles of millions of patients globally."

    ABOUT ENVISTA HOLDINGS CORPORATION

    Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Its comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit www.envistaco.com. 

    FOR FURTHER INFORMATION 

    Melissa Morrison 

    Vice President, Communication

    Envista Holdings Corporation 

    200 S. Kraemer Blvd., Building E 

    Brea, CA 92821 

    Telephone: (714) 817-7000 

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/envista-holdings-corporation-announces-key-leadership-appointments-302197149.html

    SOURCE Envista Holdings Corporation

    Get the next $NVST alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NVST

    DatePrice TargetRatingAnalyst
    12/4/2024$20.00Underperform
    Mizuho
    10/31/2024$16.00 → $23.00Underperform → Market Perform
    Leerink Partners
    10/8/2024$20.00Equal Weight
    Wells Fargo
    8/8/2024$23.00 → $16.00Overweight → Neutral
    JP Morgan
    4/26/2024$33.00 → $21.00Overweight → Equal-Weight
    Morgan Stanley
    2/26/2024$19.00Underperform
    Leerink Partners
    2/9/2024$30.00 → $23.00Buy → Hold
    Jefferies
    2/8/2024Outperform → Mkt Perform
    William Blair
    More analyst ratings

    $NVST
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Envista Reports First Quarter 2025 Results

      BREA, Calif., May 1, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced results for the quarter ended March 28, 2025. "In the first quarter, Envista delivered results in line with our expectations building on the momentum established across the second half of 2024," said Paul Keel, CEO. "We continued to drive improvements across our three priority areas of growth, operations, and people. This was a solid start to the year, and we are maintaining our 2025 guidance." Q1 2025 financial highlights: Sales were $617 million, with core sales increasing 0.2%

      5/1/25 4:05:00 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Envista Schedules First Quarter 2025 Earnings Call

      BREA, Calif., April 8, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") will report financial results for its first quarter 2025 on Thursday, May 1, 2025. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour.  The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. You ca

      4/8/25 4:15:00 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Envista Smile Project Donates $1.8 Million in 2024

      BREA, Calif., Feb. 25, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") proudly announced that in 2024, the Envista Smile Project (Smile Project) contributed $1.8 million to further its mission of enhancing oral health accessibility for underserved communities. Since its inception in 2021, the Envista Smile Project has delivered over $4.2 million in dental goods and services, positively impacting approximately 32,000 individuals worldwide. In 2024, the Envista Smile Project: Supplied free dental care to more than 787 patients in the Dominican Republic.

      2/25/25 4:10:00 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care

    $NVST
    Financials

    Live finance-specific insights

    See more
    • Envista Reports First Quarter 2025 Results

      BREA, Calif., May 1, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced results for the quarter ended March 28, 2025. "In the first quarter, Envista delivered results in line with our expectations building on the momentum established across the second half of 2024," said Paul Keel, CEO. "We continued to drive improvements across our three priority areas of growth, operations, and people. This was a solid start to the year, and we are maintaining our 2025 guidance." Q1 2025 financial highlights: Sales were $617 million, with core sales increasing 0.2%

      5/1/25 4:05:00 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Envista Schedules First Quarter 2025 Earnings Call

      BREA, Calif., April 8, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") will report financial results for its first quarter 2025 on Thursday, May 1, 2025. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour.  The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. You ca

      4/8/25 4:15:00 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Envista Reports Fourth Quarter 2024 Results

      BREA, Calif., Feb. 5, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced results for the quarter ended December 31, 2024. "In Q4 2024, Envista delivered results that were in line with expectations, indicating that our focus on growth, operations, and people is having a positive impact," said Paul Keel, Envista's CEO.  "2024 was a transition year for our company.  After a challenging first half, we took actions over the last two quarters to position ourselves for improved performance moving forward.  While we still have much more to do, we're encourag

      2/5/25 4:05:00 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care

    $NVST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Envista Holdings Corporation

      SC 13G - Envista Holdings Corp (0001757073) (Subject)

      11/8/24 12:09:03 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Envista Holdings Corporation (Amendment)

      SC 13G/A - Envista Holdings Corp (0001757073) (Subject)

      2/15/24 10:19:33 AM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by Envista Holdings Corporation

      SC 13G - Envista Holdings Corp (0001757073) (Subject)

      2/14/24 4:08:38 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care

    $NVST
    Leadership Updates

    Live Leadership Updates

    See more
    • QuidelOrtho Announces Appointment of Two Independent Directors to its Board

      Veteran Healthcare CEOs John R. Chiminski and R. Scott Huennekens Bring Deep Industry Experience, Operational Expertise and Financial Acumen to the QuidelOrtho Board QuidelOrtho Corporation (NASDAQ:QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced the appointments of John R. Chiminski and R. Scott Huennekens to its board of directors (the "Board"), effective December 6, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241210769572/en/R. Scott Huennekens (Photo: Business Wire) T

      12/10/24 7:00:00 AM ET
      $CTLT
      $HYPR
      $NVST
      $QDEL
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Medical/Dental Instruments
    • Compass Diversified Announces Stephen Keller as Chief Financial Officer

      WESTPORT, Conn., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE:CODI) ("CODI" or the "Company"), an owner of leading middle market businesses, announced today that Stephen Keller has been appointed as the Company's Chief Financial Officer (CFO), effective August 31, 2024. He will be replacing Ryan Faulkingham, who has served as the Company's CFO since July 2013 and is departing the Company effective August 30, 2024. Mr. Faulkingham will continue to serve in an advisory capacity in order to facilitate a seamless transition. In his new role, Mr. Keller will lead CODI's finance organization, including accounting, planning, treasury, tax, reporting, and investor relations. He b

      8/26/24 6:00:00 AM ET
      $AVY
      $CODI
      $NVST
      Containers/Packaging
      Consumer Discretionary
      Home Furnishings
      Medical/Dental Instruments
    • Envista Holdings Corporation Announces Key Leadership Appointments

      BREA, Calif., July 15, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced the following key leadership appointments: Eric Hammes joins Envista as Chief Financial OfficerStefan Nilsson joins Envista as President, Nobel BiocareVeronica Acurio joins Envista as President, Ormco"It is a pleasure to welcome this trio of successful leaders to Envista," said Paul Keel, Chief Executive Officer. "Each brings experience in dental along with a proven track record of continuous improvement, leading with purpose, and creating value for all stakeholders. Today's an

      7/15/24 4:10:00 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care

    $NVST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Keel Paul A bought $506,100 worth of shares (30,000 units at $16.87), increasing direct ownership by 8% to 402,605 units (SEC Form 4)

      4 - Envista Holdings Corp (0001757073) (Issuer)

      8/14/24 4:40:20 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Chief Financial Officer Hammes Eric D. bought $400,608 worth of shares (24,532 units at $16.33) (SEC Form 4)

      4 - Envista Holdings Corp (0001757073) (Issuer)

      8/13/24 6:01:10 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Conley Eric bought $50,015 worth of shares (2,185 units at $22.89), increasing direct ownership by 5% to 47,376 units (SEC Form 4)

      4 - Envista Holdings Corp (0001757073) (Issuer)

      11/20/23 5:49:32 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care

    $NVST
    SEC Filings

    See more
    • SEC Form 10-Q filed by Envista Holdings Corporation

      10-Q - Envista Holdings Corp (0001757073) (Filer)

      5/1/25 4:17:13 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Envista Holdings Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Envista Holdings Corp (0001757073) (Filer)

      5/1/25 4:10:29 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • SEC Form DEFA14A filed by Envista Holdings Corporation

      DEFA14A - Envista Holdings Corp (0001757073) (Filer)

      4/24/25 4:14:05 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care

    $NVST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Accounting Officer Kaabi Faez C covered exercise/tax liability with 4,319 shares and was granted 9,685 shares, increasing direct ownership by 12% to 49,996 units (SEC Form 4)

      4 - Envista Holdings Corp (0001757073) (Issuer)

      2/27/25 5:27:45 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • SVP, Strategy & Bus. Dev. Reis Mischa covered exercise/tax liability with 3,813 shares and was granted 8,475 shares, increasing direct ownership by 11% to 47,382 units (SEC Form 4)

      4 - Envista Holdings Corp (0001757073) (Issuer)

      2/27/25 5:27:34 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Chief Executive Officer Keel Paul A was granted 65,830 shares, increasing direct ownership by 19% to 414,439 units (SEC Form 4)

      4 - Envista Holdings Corp (0001757073) (Issuer)

      2/27/25 5:27:24 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care

    $NVST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Mizuho initiated coverage on Envista with a new price target

      Mizuho initiated coverage of Envista with a rating of Underperform and set a new price target of $20.00

      12/4/24 7:46:09 AM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Envista upgraded by Leerink Partners with a new price target

      Leerink Partners upgraded Envista from Underperform to Market Perform and set a new price target of $23.00 from $16.00 previously

      10/31/24 6:27:39 AM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Wells Fargo initiated coverage on Envista with a new price target

      Wells Fargo initiated coverage of Envista with a rating of Equal Weight and set a new price target of $20.00

      10/8/24 7:32:45 AM ET
      $NVST
      Medical/Dental Instruments
      Health Care